Endo Pharmaceuticals is a highly dedicated generics and specialty branded pharmaceutical company. The company believes in delivering quality medicinal products through excellence in development, manufacturing and commercialization.
The company through its operating companies like Endo Pharmaceuticals, Par Pharmaceutical and Paladin Labs – This Endo is devoted to serve people in need. This company commenced operations in 1997 by acquiring pharmaceutical products.
The strategy of the Endo Pharmaceuticals is to centralize and unify its business, driving productivity improvements. It focuses on organic growth by investing in hard-to-produce generic assets & technologies and transforming the branded business into a highly focused Specialty business.
The company concentrates on differentiated and intelligent product selection to shape the company for long-term success. The internal development, corporate and business development teams evaluate product and company acquisitions time by time. The licenses and strategic alliances also analyze the products in order to create a robust portfolio of quality medicines. Endo Pharmaceuticals has global headquarters at different locations such as Dublin, Ireland and U.S. headquarters in Malvern, Pennsylvania. The company is a family of 300 people globally.